Menopause and aging: Changes in the immune system - A review

Maturitas

Volumn 67, Issue 4, 2010, Pages 316-320

  Gameiro, Cátia Morgado ^a   Romão, Fatima ^a   Castelo Branco, Camil ^b  

^a Department of Gynaecology and Obstetrics   (Portugal)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Aging; Cytokines; Immune system; Immunosenescence; Menopause; Sex steroids

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTROGEN; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

AGING; ATHEROSCLEROSIS; B LYMPHOCYTE; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; DATA BASE; DIABETES MELLITUS; ESTROGEN THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MENOPAUSE; NATURAL KILLER CELL; NONHUMAN; OSTEOLYSIS; REVIEW;

AGING; BONE RESORPTION; CYTOKINES; ESTROGENS; FEMALE; HUMANS; IMMUNE SYSTEM; POSTMENOPAUSE;

ANIMALIA;

EID: 78649522730     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.08.003     Document Type: Review

References (56)

1. L. Dennerstein Well-being, symptoms and the menopausal transition Maturitas 23 2 1996 147 157
2. L. Dennerstein, E.C. Dudley, J.L. Hopper, J.R. Guthrie, and H.G. Burgr A prospective population-based study of menopausal symptoms Obstet Gynecol Obstet 96 3 2000 351 358
3. C.J. Grossman, G.A. Roselle, and C.L. Mendenhall Sex steroid regulation of autoimmunity J Steroid Biochem Mol Biol 40 1991 649 659
4. D. Weiskopf, B. Weinbereger, and B. Grubeck-Loebenstein Theaging of the immune system Transpl Int 22 November (11) 2009 1041 1050
5. K.S. Krabbe, M. Pedersen, and H. Brunsgaard Inflammatory mediators in the elderly Exp Gerontol 39 5 2004 687 699
6. N.J. Olsen, and W.J. Kovacs Gonadal steroids and immunity Endocr Rev 17 4 1996 369 384
7. S.F. Medeiros, V.N. Oliveira, and M.M.W. Yamamoto Epidemiologia clínica do climatério Reprod Clim 18 1 2003 79 86
8. H.O. Basedovsky, and A. Del Rey Immune-neuro-endocrine interactions: facts and hypotheses Endocr Rev 17 1 1996 64 102
9. S.F. Medeiros, M. Alexandre, and A.P.B. Nince Efeitos da terapia hormonal na menopausa sobre o sistema imune Rev Brás Ginecol Obestet 29 11 2007 593 601
10. A.R. Goldsby, J.T. Kindt, and A.B. Osborne Kuby immunology Fourth ed. 2000 508 509 Chapter 20
11. H.N. Ho, M.Y. Wu, and H.F. Chen In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a) Am J Reprod Immunol 33 1 1995 134 139
12. M. Cutolo, S. Capellino, and A. Sulli Estrogens and autoimmune diseases Ann N Y Acad Sci 1089 November 2006 538 547
13. M. Faas, A. Bouman, H. Moes, M.J. Heineman, L. de Leij, and G. Schuiling The immune response during the luteal phase of the ovarian cycle: a Th2-type response? Fertil Steril 74 5 2000 1008 1013
14. K. Shakhar, G. Shakhar, E. Rosenne, and S. Ben-Eliyahu Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity Br J Cancer 83 12 2000 1630 1636
15. H.D. White, K.M. Crassi, and A.L. Givan CD3+CD8+CTL activity within the human female reproductive tract: influence of stage of menstrual cycle and menopause J Immunol 158 6 1997 3017 3027
16. A.C. Tonet, and O.T. Nóbrega Immunosenescence: the association between leukocytes, cytokines and chronic diseases Rev Bras Geriatr Gerontol 11 2 2008 259 273
17. D. Weiskopf, B. Weinberger, and B. Grubeck-Loebenstein The aging of the immune system Transpl Int 22 November (11) 2009 1041 1050 Epub 2009 July 16
18. A. Grolleau- Julius, D. Ray, and R.L. Yung The role of epigenetics in agin and autoimmunity Clin Rev Allergy Immunol 39 August (1) 2010 42 50
19. N. Khansari, Y. Shakiba, and M. Mahmoidi Chronic inflammation and oxidative stress as a major cause of age-related disease and cancer Recent Pat Inflamm Allergy Drug Discov 3 1 2009 73 80
20. T. Giglio, M.A. Imro, and G. Filaci Immune cell circulating subsets are affected by gonadal function Life Sci 54 18 1994 1305 1312
21. M. Kamada, M. Irahara, and M. Maegawa Postmenopausal changes in serum cytokine levels and hormone replacement therapy Am J Obstet Gynecol 184 3 2001 309 314 (Pubitemid 32206977)
22. T. Yasui, M. Maegawa, and J. Tomita Changes in serum cytokine concentrations during the menopausal transition Maturitas 56 4 2007 396 403 (Pubitemid 46401105)
23. M. Cioffi, K. Esposito, and M.T. Vietri Cytocine patern in postmenopauce Maturitas 41 2002 187 192
24. C.B. Coulam, and J.J. Stern Immunology of ovarian failure Am J Reprod Immunol 25 4 1991 169 174
25. J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in proinflammatory cytokine activity after menopause Endocr Rev 23 1 2002 90 119
26. Y. Toshiyuki, U. Hirokazu, and Y. Masayo Associations of interleukin-6 with interleukin 1Beta, interleukin-8 and macrophage inflammatory protein 1Beta in midlife women Cytokine 41 2008 302 306
27. B. William, S. Ershler, M. Harman, and T. Even Immunologic aspects of osteoporosis Dev Comp Immunol 21 1997 487 499
28. R. Pacifici Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis J Bone Miner Res 11 1996 1043 1051
29. R.H. Straub, H.W. Hense, T. Andus, J. Scholmerich, G.A. Riegger, and H. Schunkert Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study J Clin Endocrinol Metab 85 3 2000 1340 1344
30. E.M. Brooks-Asplund, C.E. Tupper, J.M. Daun, W.L. Kenney, and J.G. Cannon Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women Cytokine 19 4 2002 193 200
31. M. Blum, D. Zacharovich, J. Pery, and E. KitAi Lowering effect of estrogen replacement treatment on immunoglobolins in menopausal women Rev Fr Gynecol Obstet 85 4 1990 207 209
32. U. Stopinska-Gluszack, J. Waligóra, and T. Grazela Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal womem J Reprod Immunol 69 1 2006 65 75
33. T.A. Ryan-Borchers, J.S. Park, B.P. Chew, M.K. McGuire, L.R. Fournier, and K.A. Beerman Soy isoflavones modulate immune function in helthy postmenopausal women Am J Clin Nutr 83 5 2006 1118 1125
34. K.K. Koh, W.H. Schenke, M. Waclawiw, G. Csako, and R.O. Cannon III Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women Circulation 105 2002 1531 1533
35. M. Cushman, C. Legault, and E. Barrett-Connor Effect of postmenopausal hormones on inflammation-sensitive proteins. The postmenopausal estrogen/progestin interventions (PEPI) study Circulation 100 1999 717 722
36. S. Vehkavaara, A. Silveira, and T. Hakala-Ala-Pietila Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women Thromb Haemost 85 2001 619 625
37. D.M. Herrington, K.B. Brosnihan, and B.E. Pusser Differential effects of estrogen and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women J Clin Endocrinol Metab 86 2001 4216 4222
38. M. Cushman, E.N. Meilahn, B.M. Psaty, L.H. Kuller, A.S. Dobs, and R.P. Tracy Hormone replacement therapy, inflammation, and hemostasis in elderly women Arterioscler Thromb Vasc Biol 19 1999 893 899
39. B.W. Walsh, D.A. Cox, A. Sashegyi, R.A. Dean, R.P. Tracy, and P.W. Anderson Role of tumor necrosis factor-α and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women Am J Cardiol 88 2001 825 828
40. A. Silvestri, O. Gebara, and C. Vitale Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response Circulation 107 2003 3165 3169
41. A. Decensi, U. Omodei, and C. Robertson Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women Circulation 106 2002 1224 1228
42. N. Sattar, M. Perera, M. Small, and M.A. Lumsden Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes Lancet 354 1999 487 488
43. M.G. Modena, F. Bursi, and G. Fantini Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women J Clin Endocrinol Metab 90 2005 3230 3235
44. T. Caulin-Glaser, C.A. Watson, R. Pardi, and J.R. Bender Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression J Clin Invest 98 1996 36 42
45. A.P. Miller, W. Feng, and D. Xing Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries Circulation 110 2004 1664 1669
46. A. Wakatsuki, Y. Okatani, N. Ikenoue, and T. Fukaya Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen Circulation 105 2002 1436 1439
47. S. Lamon-Fava, B. Posfai, and E.J. Schaefer Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women Am J Cardiol 91 2003 252 254
48. K.K. Koh, M.N. Bui, R. Mincemoyer, and R.O. Cannon III Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women Am J Cardiol 80 1997 1505 1507
49. K.K. Koh, A. Blum, and L. Hathaway Vascular effects of estrogen and vitamin E therapies in postmenopausal women Circulation 100 1999 1851 1857
50. K.K. Koh, D.K. Jin, and S.H. Yang Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women Circulation 103 2001 1961 1966
51. S. Pervin, R. Singh, M.E. Rosenfeld, M. Navab, G. Chaudhuri, and L. Nathan Estradiol suppresses MCP-1 expression in vivo: implications for atherosclerosis Arterioscler Thromb Vasc Biol 18 1998 1575 1582
52. S. Stork, K. Baumann, C. von Schacky, and P. Angerer The effect of 17 beta-estradiol on MCP-1 serum levels in postmenopausal women Cardiovasc Res 53 2002 642 649
53. K.K. Koh, J.W. Son, and D.K. Jin Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels Int J Cardiol 81 2001 43 50
54. S. Srivastava, M.N. Weitzmann, S. Cenci, F.P. Ross, S. Adler, and R. Pacifici Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD J Clin Invest 104 1999 503 513
55. K.K. Koh, J.Y. Ahn, and D.K. Jin Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women Arterioscler Thromb Vasc Biol 22 2002 1459 1464
56. D.A. Sukovich, K. Kauser, F.D. Shirley, V. DelVecchio, M. Halks-Miller, and G.M. Rubanyi Expression of interleukin-6 in atherosclerotic lesions of male apoE-knockout mice Arterioscler Thromb Vasc Biol 18 1998 1498 1505